These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 7902777

  • 1. Expression of squamous cell carcinoma-associated antigen in grade 3 pT1 transitional cell carcinoma of the bladder and prediction of its progression and intravesical recurrence.
    Yamazaki K, Kumamoto Y, Tsukamoto T.
    Cancer; 1993 Dec 15; 72(12):3676-84. PubMed ID: 7902777
    [Abstract] [Full Text] [Related]

  • 2. [Expression of squamous cell carcinoma-associated antigen in bladder cancer cells--a comparative study with the expression of proliferating cell nuclear antigen (PCNA)].
    Yamazaki K, Kumamoto Y, Tsukamoto T.
    Nihon Hinyokika Gakkai Zasshi; 1994 Apr 15; 85(4):589-98. PubMed ID: 7910645
    [Abstract] [Full Text] [Related]

  • 3. Microstaging of pT1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pT1 subcategory).
    Sözen S, Akbal C, Sökmensüer C, Ekici S, Ozen H.
    Urol Int; 2002 Apr 15; 69(3):200-6. PubMed ID: 12372888
    [Abstract] [Full Text] [Related]

  • 4. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS, Chow NH, Lin JS, Yang WH, Tong YC.
    Anticancer Res; 1998 Apr 15; 18(6B):4717-21. PubMed ID: 9891547
    [Abstract] [Full Text] [Related]

  • 5. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G, Yu J, Song H, Zhu S, Sun L, Shang Z, Niu Y.
    BMC Cancer; 2017 Aug 08; 17(1):530. PubMed ID: 28789622
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
    Shiina H, Igawa M, Nagami H, Yagi H, Urakami S, Yoneda T, Shirakawa H, Ishibe T, Kawanishi M.
    Cancer; 1996 Oct 15; 78(8):1762-74. PubMed ID: 8859190
    [Abstract] [Full Text] [Related]

  • 7. [Expression of proliferating cell nuclear antigen in superficial bladder cancer--application to paraffin-embedded tissue sections].
    Wada T, Shimabukuro T, Kurisu H, Shameem IA, Yoshihiro S, Matsuyama H, Naito K, Hashimoto O, Tanaka K.
    Hinyokika Kiyo; 1993 Apr 15; 39(4):313-9. PubMed ID: 8099249
    [Abstract] [Full Text] [Related]

  • 8. The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer.
    Nonomura N, Nakai Y, Nakayama M, Inoue H, Nishimura K, Hatanaka E, Arima R, Kishimoto T, Miki T, Kuroda H, Okuyama A.
    Int J Clin Oncol; 2006 Aug 15; 11(4):297-302. PubMed ID: 16937303
    [Abstract] [Full Text] [Related]

  • 9. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I, Miyake H, Harada K, Hara I, Inoue TA, Fujisawa M.
    Int J Urol; 2006 Nov 15; 13(11):1389-92. PubMed ID: 17083389
    [Abstract] [Full Text] [Related]

  • 10. [A clinical study of recurrence and progression of grade 3 superficial bladder tumor].
    Ikegami S, Tsuji A, Suzuki S, Sumitomo M, Kimura F, Asano T, Nakajima F, Hayakawa M.
    Hinyokika Kiyo; 1999 May 15; 45(5):325-9. PubMed ID: 10410314
    [Abstract] [Full Text] [Related]

  • 11. E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder.
    Mahnken A, Kausch I, Feller AC, Krüger S.
    Oncol Rep; 2005 Oct 15; 14(4):1065-70. PubMed ID: 16142373
    [Abstract] [Full Text] [Related]

  • 12. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF, Bolenz C, Godoy G, Fradet Y, Ashfaq R, Karakiewicz PI, Isbarn H, Jeldres C, Rigaud J, Sagalowsky AI, Lotan Y.
    J Urol; 2009 Jul 15; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [Abstract] [Full Text] [Related]

  • 13. Squamous cell carcinoma-associated antigen in uroepithelial carcinoma.
    Tsukamoto T, Kumamoto Y, Ohmura K, Miyao N, Nammbu A, Takagi Y, Itoh N.
    Urology; 1992 Nov 15; 40(5):477-83. PubMed ID: 1441052
    [Abstract] [Full Text] [Related]

  • 14. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
    Divrik RT, Sahin A, Altok M, Unlü N, Zorlu F.
    J Urol; 2007 Sep 15; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
    [Abstract] [Full Text] [Related]

  • 15. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.
    Jones HL, Delahunt B, Bethwaite PB, Thornton A.
    Anticancer Res; 1997 Sep 15; 17(1B):685-7. PubMed ID: 9066602
    [Abstract] [Full Text] [Related]

  • 16. CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
    Omran OM.
    J Environ Pathol Toxicol Oncol; 2012 Sep 15; 31(3):203-12. PubMed ID: 23339695
    [Abstract] [Full Text] [Related]

  • 17. Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
    Shariat SF, Zippe C, Lüdecke G, Boman H, Sanchez-Carbayo M, Casella R, Mian C, Friedrich MG, Eissa S, Akaza H, Sawczuk I, Serretta V, Huland H, Hedelin H, Rupesh R, Miyanaga N, Sagalowsky AI, Wians F, Roehrborn CG, Lotan Y, Perrotte P, Benayoun S, Marberger MJ, Karakiewicz PI.
    J Urol; 2005 May 15; 173(5):1518-25. PubMed ID: 15821471
    [Abstract] [Full Text] [Related]

  • 18. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E, Iborra I, Rubio J, Casanova J, Almenar S.
    BJU Int; 2004 Dec 15; 94(9):1258-62. PubMed ID: 15610101
    [Abstract] [Full Text] [Related]

  • 19. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients].
    Zhang H, Zhao Z, Sun H.
    Zhonghua Wai Ke Za Zhi; 1996 Sep 15; 34(9):560-2. PubMed ID: 9594163
    [Abstract] [Full Text] [Related]

  • 20. [Immunohistochemical study of tissue polypeptide antigen (TPA) in human urinary bladder tumors].
    Kaneko K, Suzuki T, Takasaki E.
    Nihon Hinyokika Gakkai Zasshi; 1989 Oct 15; 80(10):1430-5. PubMed ID: 2601216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.